In all cases, this confirmed responsiveness to NFE2L2 siRNA silencing in A549, as well as one additional lung cancer cell line, H838, which similarly harbours a loss-of-function mutation in KEAP1 (Fig. 5b). Here, NFE2L2 is linked to lung carcinoma.